HCPCS Level II drug code
J1885 — Injection, ketorolac tromethamine, per 15 mg
In short
J1885 is the HCPCS Level II code for injection, ketorolac tromethamine, per 15 mg. CMS assigns NDCs for Ketorolac Tromethamine to it. One billing unit is 15 mg. The Medicare Part B payment limit is $0.569 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS fileHCPCS codeJ1885
Billing unit15 mg
- Descriptor
- Injection, ketorolac tromethamine, per 15 mg
- Short descriptor
- Ketorolac tromethamine inj
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2025
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP filePayment limit per unit$0.569
Per15 mg
Coinsurance20%
Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 15 mg. For example, 1500 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J1885
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 71 NDCs to J1885 for Ketorolac Tromethamine. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Ketorolac Tromethamine | 00338-0069-10 | Baxter Healthcare Corporation | 10 × 1 | 10 |
| Ketorolac Tromethamine | 00338-0072-25 | Baxter Healthcare Corporation | 25 × 1 | 50 |
| Ketorolac Tromethamine | 00404-9952-01 | Henry Schein Inc. | 1 | 1 |
| Ketorolac Tromethamine | 00404-9996-01 | Henry Schein Inc. | 1 | 2 |
| Ketorolac Tromethamine | 00404-9997-02 | Henry Schein Inc. | 2 | 4 |
| Ketorolac Tromethamine | 00404-9998-01 | Henry Schein Inc. | 1 | 1 |
| Ketorolac Tromethamine | 00409-3793-01 | Pfizer Inc | 25 × 1 | 25 |
| Ketorolac Tromethamine | 00409-3793-25 | Pfizer Inc | 25 × 1 | 25 |
| Ketorolac Tromethamine | 00409-3795-01 | Pfizer Inc | 25 × 1 | 50 |
| Ketorolac Tromethamine | 00409-3795-25 | Pfizer Inc | 25 × 1 | 50 |
| Ketorolac Tromethamine | 00409-3796-01 | Pfizer Inc | 25 × 2 | 100 |
| Ketorolac Tromethamine | 00409-3796-25 | Pfizer Inc | 25 × 2 | 100 |
| Ketorolac Tromethamine | 00487-6232-01 | Nephron SC, Inc. | 30 × 2 | 120 |
| Ketorolac Tromethamine | 25021-0700-01 | Sagent Pharmaceuticals | 25 × 1 | 25 |
| Ketorolac Tromethamine | 25021-0701-01 | Sagent Pharmaceuticals | 25 × 1 | 50 |
| Ketorolac Tromethamine | 25021-0701-02 | Sagent Pharmaceuticals | 25 × 2 | 100 |
| Ketorolac Tromethamine | 50090-1328-01 | A-S Medication Solutions | 2 | 4 |
| Ketorolac Tromethamine | 50090-3364-00 | A-S Medication Solutions | 25 × 1 | 50 |
| Ketorolac Tromethamine | 50090-3364-01 | A-S Medication Solutions | 25 × 1 | 50 |
| Ketorolac Tromethamine | 50090-3397-01 | A-S Medication Solutions | 25 × 2 | 100 |
| Ketorolac Tromethamine | 50090-4583-00 | A-S Medication Solutions | 25 × 2 | 100 |
| Ketorolac Tromethamine | 50090-4635-00 | A-S Medication Solutions | 25 × 2 | 100 |
| Ketorolac Tromethamine | 50090-4635-01 | A-S Medication Solutions | 2 | 4 |
| Ketorolac Tromethamine | 50090-5013-00 | A-S Medication Solutions | 25 × 1 | 50 |
| Ketorolac Tromethamine | 50090-5013-01 | A-S Medication Solutions | 1 | 2 |
| Ketorolac Tromethamine | 50090-5428-00 | A-S Medication Solutions | 25 × 1 | 50 |
| Ketorolac Tromethamine | 50090-5428-01 | A-S Medication Solutions | 1 | 2 |
| Ketorolac Tromethamine | 50090-5609-00 | A-S Medication Solutions | 25 × 1 | 25 |
| Ketorolac Tromethamine | 50090-6772-00 | A-S Medication Solutions | 25 × 2 | 100 |
| Ketorolac Tromethamine | 50090-6772-01 | A-S Medication Solutions | 2 | 4 |
| Ketorolac Tromethamine | 50090-6807-00 | A-S Medication Solutions | 25 × 1 | 25 |
| Ketorolac Tromethamine | 51662-1292-01 | HF Acquisition Co. LLC, DBA HealthFirst | 1 | 2 |
| Ketorolac Tromethamine | 51662-1292-03 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 1 | 50 |
| Ketorolac Tromethamine | 51662-1295-01 | HF Acquisition Co. LLC, DBA HealthFirst | 2 | 4 |
| Ketorolac Tromethamine | 51662-1295-03 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 2 | 100 |
| Ketorolac Tromethamine | 51662-1594-03 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 1 | 50 |
| Ketorolac Tromethamine | 62332-0599-25 | Alembic Pharmaceuticals Inc. | 25 × 1 | 25 |
| Ketorolac Tromethamine | 62332-0600-25 | Alembic Pharmaceuticals Inc. | 25 × 1 | 50 |
| Ketorolac Tromethamine | 62332-0601-25 | Alembic Pharmaceuticals Inc. | 25 × 2 | 100 |
| Ketorolac Tromethamine | 63323-0161-01 | FreseniUS Kabi USA, LLC | 25 × 1 | 25 |
| Ketorolac Tromethamine | 63323-0161-12 | FreseniUS Kabi USA, LLC | 25 × 1 | 25 |
| Ketorolac Tromethamine | 63323-0161-16 | FreseniUS Kabi USA, LLC | 25 × 1 | 25 |
| Ketorolac Tromethamine | 63323-0162-01 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| Ketorolac Tromethamine | 63323-0162-02 | FreseniUS Kabi USA, LLC | 25 × 2 | 100 |
| Ketorolac Tromethamine | 63323-0162-12 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| Ketorolac Tromethamine | 63323-0162-14 | FreseniUS Kabi USA, LLC | 25 × 2 | 100 |
| Ketorolac Tromethamine | 63323-0162-16 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| Ketorolac Tromethamine | 63323-0162-26 | FreseniUS Kabi USA, LLC | 25 × 2 | 100 |
| Ketorolac Tromethamine | 65145-0145-25 | Caplin Steriles USA Inc. | 25 × 1 | 50 |
| Ketorolac Tromethamine | 65145-0146-25 | Caplin Steriles USA Inc. | 25 × 1 | 25 |
| Ketorolac Tromethamine | 65145-0147-25 | Caplin Steriles USA Inc. | 25 × 2 | 100 |
| Ketorolac Tromethamine | 68462-0755-25 | Glenmark Pharmaceuticals Inc., USA | 25 × 1 | 25 |
| Ketorolac Tromethamine | 68462-0756-25 | Glenmark Pharmaceuticals Inc., USA | 25 × 1 | 50 |
| Ketorolac Tromethamine | 68462-0757-25 | Glenmark Pharmaceuticals Inc., USA | 25 × 2 | 100 |
| Ketorolac Tromethamine | 70512-0842-25 | Sola Pharmaceuticals | 25 × 1 | 25 |
| Ketorolac Tromethamine | 70512-0843-25 | Sola Pharmaceuticals | 25 × 1 | 50 |
| Ketorolac Tromethamine | 70512-0844-25 | Sola Pharmaceuticals | 25 × 2 | 100 |
| Ketorolac Tromethamine | 70860-0700-02 | Athenex Pharmaceutical Division, LLC | 25 × 1 | 25 |
| Ketorolac Tromethamine | 70860-0701-03 | Athenex Pharmaceutical Division, LLC | 25 × 1 | 50 |
| Ketorolac Tromethamine | 70860-0701-04 | Athenex Pharmaceutical Division, LLC | 25 × 2 | 100 |
Showing 60 of 71. The full list is in the CMS crosswalk file.
J1885: common questions
- Is J1885 a CPT code?
- No. J1885 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J1885?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 71 NDCs under J1885, for Ketorolac Tromethamine. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J1885?
- $0.569 per 15 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J1885?
- One unit of J1885 is 15 mg, as stated in the code's descriptor. Units to report = dose given ÷ 15 mg. J-code billing units.